Clinical Study Validates the Benefits of Jarrow Formulas® BioSil(TM)
Los Angeles, California, Friday, January 17, 2005– The results of a clinical trial investigating the effects of Jarrow Formulas® BioSil™ on sun damaged or prematurely aging skin, was presented at the International Symposium of the International Society for Bioengineering and the Skin, held in Orlando, FL October 28th, 2004.
Scientists at the Free University of Brussels conducted a 20-week double-blind placebo controlled study using 50 women ages 40 to 65, who had clear signs of sun damaged or prematurely aging skin. Half received 10 mg of BioSil™, while the other half received a placebo. The BioSil™ group experienced a significant improvement over the placebo group including:
• Shallower micro wrinkles: up to 30 percent better than placebo
• Improved skin elasticity: 55 percent better than placebo
• Significant reduction of brittleness in hair and nails
BioSil™ (US patent 5,922,360 and other patents pending) is a silicon supplement which contains a choline-stabilized and concentrated form of orthosilicic acid, ch-OSA™. Silicon is a key component in hair, skin and nails, and is essential for optimal formation of collagen. The observed improvement in skin parameters is likely the result of ch-OSA’s role in the regeneration or de novo synthesis of collagen fibers.
"This is promising news for women who want a safe, noninvasive way to address the effects of sun damage or prematurely aging skin," said principal investigator Professor A. Barel. "While further studies are warranted, this work indicates that using BioSil™ may represent a viable oral treatment, and an alternative or complementary treatment to topical products."
Jarrow Formulas® BioSil™ is available in health food stores and can be purchased as a liquid in 30 ml dropper bottles or in vegetarian capsules.